English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/220134
Share/Impact:
Statistics
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE
Exportar a otros formatos:

Title

Inhibitory effects of peptide lunasin in colorectal cancer HCT-116 cells and their tumorsphere-derived subpopulation

AuthorsFernández-Tomé, Samuel ; Xu, Fei ; Han, Yanhui; Hernández-Ledesma, Blanca ; Xiao, Hang
KeywordsColorectal cancer
Bioactive peptide
Cancer stem cells
Chemoprevention
Lunasin
Issue Date2020
PublisherMultidisciplinary Digital Publishing Institute
CitationInternational Journal of Molecular Sciences 21(2): 537 (2020)
AbstractThe involvement of cancer stem-like cells (CSC) in the tumor pathogenesis has profound implications for cancer therapy and chemoprevention. Lunasin is a bioactive peptide from soybean and other vegetal sources with proven protective activities against cancer and other chronic diseases. The present study focused on the cytotoxic effect of peptide lunasin in colorectal cancer HCT-116 cells, both the bulk tumor and the CSC subpopulations. Lunasin inhibited the proliferation and the tumorsphere-forming capacity of HCT-116 cells. Flow cytometry results demonstrated that the inhibitory effects were related to apoptosis induction and cell cycle-arrest at G1 phase. Moreover, lunasin caused an increase in the sub-GO/G1 phase of bulk tumor cells, linked to the apoptotic events found. Immunoblotting analysis further showed that lunasin induced apoptosis through activation of caspase-3 and cleavage of PARP, and could modulate cell cycle progress through the cyclin-dependent kinase inhibitor p21. Together, these results provide new evidence on the chemopreventive activity of peptide lunasin on colorectal cancer by modulating both the parental and the tumorsphere-derived subsets of HCT-116 cells.
DescriptionThis article belongs to the Special Issue Peptides for Health Benefits 2019.
Publisher version (URL)https://doi.org/10.3390/ijms21020537
URIhttp://hdl.handle.net/10261/220134
DOI10.3390/ijms21020537
E-ISSN1422-0067
Appears in Collections:(CIAL) Artículos
Files in This Item:
File Description SizeFormat 
inhibisubpop.pdf2,34 MBAdobe PDFThumbnail
View/Open
Show full item record
Review this work
 

Related articles:


WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.